|
ZNF529 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.38770172709269E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.51510043294923E-10 |
| Normal-vs-Stage2 |
5.433100E-04 |
| Normal-vs-Stage3 |
6.386300E-04 |
| Normal-vs-Stage4 |
1.749980E-02 |
| Stage1-vs-Stage2 |
5.743800E-01 |
| Stage1-vs-Stage3 |
2.606600E-01 |
| Stage1-vs-Stage4 |
7.952100E-02 |
| Stage2-vs-Stage3 |
2.353200E-01 |
| Stage2-vs-Stage4 |
9.684500E-02 |
| Stage3-vs-Stage4 |
5.245800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.85650000822579E-09 |
| Normal-vs-AfricanAmerican |
1.77015999999197E-05 |
| Normal-vs-Asian |
1.921740E-02 |
| Caucasian-vs-AfricanAmerican |
2.212000E-01 |
| Caucasian-vs-Asian |
2.060800E-01 |
| AfricanAmerican-vs-Asian |
3.826200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.1850000010466E-08 |
| Normal-vs-Female |
3.48590001308935E-09 |
| Male-vs-Female |
2.930000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.235700E-02 |
| Normal-vs-Age(41-60Yrs) |
5.6722004870835E-10 |
| Normal-vs-Age(61-80Yrs) |
4.07270000002402E-06 |
| Normal-vs-Age(81-100Yrs) |
5.348400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.020200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.651000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.091600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.204800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.295600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.621400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.338160E-03 |
| Normal-vs-Grade 2 |
1.82630022216301E-10 |
| Normal-vs-Grade 3 |
3.16779999998129E-06 |
| Normal-vs-Grade 4 |
2.249800E-01 |
| Grade 1-vs-Grade 2 |
4.199000E-01 |
| Grade 1-vs-Grade 3 |
1.218370E-01 |
| Grade 1-vs-Grade 4 |
2.158000E-02 |
| Grade 2-vs-Grade 3 |
7.551500E-02 |
| Grade 2-vs-Grade 4 |
3.440700E-03 |
| Grade 3-vs-Grade 4 |
7.325600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.55210313887733E-11 |
| Normal-vs-ccB subtype |
2.785800E-04 |
| ccA subtype-vs-ccB subtype |
1.833600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.41079999968785E-07 |
| Normal-vs-N1 |
3.416600E-01 |
| N0-vs-N1 |
6.099600E-01 |
|
|
